![]() |
|
|
DJ Mauro, JK De Riel, RJ Tallarida and MA Sirover
Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
Recent evidence indicates that 5-fluorouracil (5-FlUra) is incorporated into DNA and is removed by the DNA repair enzyme uracil DNA glycosylase. Synthetic oligonucleotides containing either a single uracil or 5-FlUra residue were constructed to examine the mechanisms by which human cells remove 5-FlUra from DNA. The human uracil DNA glycosylase excised uracil in a manner similar to that observed for the bacterial enzyme. In contrast, a significant difference was observed in their abilities to remove 5-FlUra. In particular, both the bacterial and normal human enzymes displayed 13-17-fold increases in their apparent Km values but the apparent Vmax values remained virtually constant. These results demonstrate that normal human cells possess a defined capacity to remove 5-FlUra incorporated into DNA. However, specific kinetic differences may exist that affect their capacity to remove 5-FlUra formed in DNA after treatment with this cancer chemotherapeutic agent.
This article has been cited by other articles:
![]() |
M. T. Morgan, M. T. Bennett, and A. C. Drohat Excision of 5-Halogenated Uracils by Human Thymine DNA Glycosylase: ROBUST ACTIVITY FOR DNA CONTEXTS OTHER THAN CpG J. Biol. Chem., September 21, 2007; 282(38): 27578 - 27586. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. An, P. Robins, T. Lindahl, and D. E. Barnes 5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity Cancer Res., February 1, 2007; 67(3): 940 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Andersen, T. Heine, R. Sneve, I. Konig, H. E. Krokan, B. Epe, and H. Nilsen Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts Carcinogenesis, March 1, 2005; 26(3): 547 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Noordhuis, U. Holwerda, C. L. Van der Wilt, C. J. Van Groeningen, K. Smid, S. Meijer, H. M. Pinedo, and G. J. Peters 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers Ann. Onc., July 1, 2004; 15(7): 1025 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-B. Lin, P. O. P. Ts'o, S.-K. Sun, K.-B. Choo, F.-Y. Yang, Y.-P. Lim, H.-L. Tsai, and L.-C. Au Inhibition of Thymidylate Synthase Activity by Antisense Oligodeoxynucleotide and Possible Role in Thymineless Treatment Mol. Pharmacol., September 1, 2001; 60(3): 474 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Farez-Vidal, C. Gallego, L. M. Ruiz-Perez, and D. Gonzalez-Pacanowska Characterization of uracil-DNA glycosylase activity from Trypanosoma cruzi and its stimulation by AP endonuclease Nucleic Acids Res., April 1, 2001; 29(7): 1549 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-S.A. Ismail, C. J. Van Groeningen, A. Hardcastle, Q.-F. Ren, G. W. Aherne, F. Geoffroy, C. J. Allegra, and J. L. Grem. Modulation of Fluorouracil Cytotoxicity by Interferon-alpha and -gamma Mol. Pharmacol., February 1, 1998; 53(2): 252 - 261. [Abstract] [Full Text] |
||||